Migraine prophylactic treatment: An update;Atualizacao no tratamento profilatico das enxaquecas

Arquivos de Neuro-Psiquiatria

Volumn 57, Issue 2 B, 1999, Pages 513-519

  Krymchantowski, Abouch Valenty ^a   Moreira Filho, Pedro Ferreira ^a  

^a R Siqueira Campos 43/1002 ^*

Author keywords

Migraine; Preventive treatment; Prophylactic treatment

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM ANTAGONIST; SEROTONIN ANTAGONIST;

ADULT; ANTICONVULSANT ACTIVITY; CHILD; DRUG ACTIVITY; GABAERGIC TRANSMISSION; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PREVALENCE; PROPHYLAXIS; REVIEW; SEROTONINERGIC SYSTEM; TREATMENT PLANNING; FEMALE; MALE;

CHILD; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS;

EID: 0033141610     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x1999000300027     Document Type: Review

References (51)

1. Stewart WF, Shechter A, Lipton RB. Migraine heterogeneity, disabilily, pain intensity, and attack frequency and duration. Neurology 1994:44(Suppl4):S24-S39.
2. Rasmussen BK Epidemiology of headache. Cephalalgia 1995;15:45-68.
3. Steward WF, Lipton RB, Simon D. Work-related disability: results from the American migraine study. Cephalalgia 1996;16:231-238.
4. Silberstein SD. Preventive treatment of migraine: an overview. Cephalalgia 1997;17:67-72.
5. Codignola A, Tarroni P, Clementi F, et al. Calcium channel subtypes controlling release from human small cell lung carcinoma cell lines. J Biol Chem 1993:268:2640-2647.
6. Ogilvie AD, Russel MB, Dhall P, et al. Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura. Cephalalgia 1998;18:23-26.
7. Goadsby PJ, Edvinson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-187.
8. Olesen J, Friberg L, Olsen TS, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990;28:791-798.
9. Olesen, J. Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligoemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-352.
10. Saxena PR. Cranial arteriovenotis shunting: an in vivo animal model for migraine. In: Olesen J. Moskowitz MA. Experimental headache models. Philadelphia: Lippincott-Raven. 1995:189-198.
11. Olesen J. Cerebral and extracranial circulatory disturbances in migraine: pathophysiological implications. Cerebrovase Brain Metab Rev 1991;3:1-28.
12. Goadsby PJ.,Knight YE, Hoskin KL. Stimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat. Pain 1997;73:23-28.
13. Spierings EL. Preventive pharmacological treatment. In Spierings EL. Management of migraine. Newton: Butterworth-Heinemann. 1996:65-104.
14. Welch KMA, Cao Y, Aurora S, Wiggins G, Vinkingstad EM. MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology 1998;51:1465-1469.
15. Lance JW. Preventive treatment of migraine. In Goadsby PJ, Silberstein S. Headache. Newton: Butterworth-Heinemann. 1998:131-142.
16. Nadelman JW, Stevens J, Saper JR. Propranolol in the prophylaxis of migraine. Headache 1986;26:175-182.
17. Johannsson V, Nilsson LR, Widelius T, et al., Atenolol in migraine prophylaxis: a double-blind cross-over multicentre study. Headache 1987;27:372-374.
18. Andersson PG, Dahl S, Hansen JH, et al., Prophylatic treatment of classic and non-classical migraine with metoprolol: a comparison with placebo. Cephalalgia 1983;3:207-212.
19. Ryan RE Sr, Ryan RE Jr., Sudilovsky A. Nadolol: its use in the prophylactic treatment of migraine. Headache 1983;23:26-31.
20. Super JR, Silberstein S, Gordon DC, Hamel RL. Handbook of headache management. Baltimore:Williams & Wilkins. 1993: 53-82.
21. Pederse E, Moller CE. Methysergide in migraine prophylaxis. Clin Pharmacol Ther 1966;7:520-526.
22. Andersson PG. BC-105 and deseril in migraine prophylaxis: a double-blind study. Headache 1973;13:68-73.
23. Couch JR, Hassanem RS. Amitriptyline in migraine prophylaxis. Arch Neurol 1979; 36:695-699.
24. Gomersall JD, Stuart A. Amitriptyline in migraine prophylaxis: changes in pattern of attacks during a controlled clinical trial. J Neurol Neurosurg Psychiatry 1973;36:684-690.
25. Krymchantowski AV. Tratamento preventivo das migrâneas on enxaquecas. JBM 1998;74:15-28.
26. Arthur GP, Homabrook RW. The treatment of migraine with BC 105 (pizotifen): a double blind trial. N Z Med J 1971;73:5-9.
27. Bassi P, Brunati L, Rapuzzi B, Alberti E, Mangoni A. Low-dose flunarizine in the prophylaxis of migraine. Headache 1992;32:390-392.
28. Sirense PS, Hansen K, Olesen J. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine. Cephalalgia 1986;6:7-14.
29. Gabai IJ, Spierings ELH. Prophylactic treatment of cluster headache with verapamil. Headache 1989;29:167-168.
30. Kahan A, Weber S, Amor B, Guerin F, Degeorges M. Nifedipine in the treatment of migraine in patients with Raynaud's phenomenon. N Engl J Med 1983; 308:1102-1103.
31. Lamsudin R, Sadjimin T. Comparison of the efficacy between flunarizine and nifedipine in the prophylaxis of migraine. Headache 1993;33:335-338.
32. Albers GW, Simon LT, Hamik A, Peroutka SJ. Nifedipine versus propranolol for the initial prophylaxis of migraine. Headache 1989; 29:214-217.
33. Migraine-Nimodipine European Study Group (MINES). European multicenter trial of nimodipine in the prophylaxis of common migraine (migraine without aura). Headache 1989;29:633-638.
34. Migraine-Nimodipine European Study Group (MINES). European multicenter trial of nimodipine in the prophylaxis of classic migraine (migraine with aura). Headache 1989; 29:639-642.
35. Leandri M, Rigardo S, Schizzi R, Parodi CI. Migraine treatment with nicardipine. Cephalalgia 1990;10:111-116.
36. Rothrock JF. Clinical studies of valproate for migraine prophylaxis. Cephalalgia 1997;17:81-83.
37. D'Andrea G, Granella F. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study (Abstr). Cephalalgia 1997;17:438.
38. Steiner TJ, Findley LJ, Yuen AWC. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 1997;17:109-112.
39. Sumun-Chauhan N, Webdale L, Hill DR, Woodruff GN. Characterization of [3H]-gabapenlin binding to a novel site in rat brain: homogenate binding studies. Eur J Pharmacol 1993;244:293-301.
40. Ziegler DK, Ellis DJ. Naproxen in prophylaxis of migraine. Arch Neurol 1985;42:582-584.
41. Mikkelsen BM, Falk JV. Prophylactic treatment of migraine with tolfenamic acid: a comparative double-blind crossover study between tolfenamic acid and placebo. Acta Neurol Scand 1982; 66:105-111.
42. Diamond S, Solomon GD, Freitag FG, Mehta ND. Fenoprofen in the prophylaxis of migraine: a double-blind, placebo controlled study. Headache 1987; 27:246-249.
43. O'Neill BP, Mann JD. Aspirin prophylaxis in migraine. Lancet 1978; 2:1179-1181.
44. Buring JE, Peto R. Hennekens CH. Low-dose aspirin for migraine prophylaxis. JAMA 1990; 264:1711-1713.
45. Kass B, Nestvold K. Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine: a comparative trial. Acta Neurol Scand 1980;61:351-356.
46. Murphy JJ, Hepinstall S, Mitehell JRA. Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988;2:189-191.
47. Schoenen J. Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 1994;14:328-329.
48. Shoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a novel prophylactic antimigraine therapy: results from a double-blind, randomized, placebo-controlled trial (Abstr). Cephalalgia 1998;17:24-1.
49. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial. Neurology 1998;50:466-470.
50. Gallai V, Sarchielli P, Morucci P, Abbritti G. Magnesium content of mononuclear blood cells in migraine patients. Headache 1994;34:160-165.
51. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multicenter, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16:257-263.